Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 1
2009 3
2010 2
2012 1
2013 3
2014 5
2015 6
2016 1
2017 2
2018 2
2019 2
2020 3
2021 4
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer's Disease.
Do KV, Hjorth E, Wang Y, Jun B, Kautzmann MI, Ohshima M, Eriksdotter M, Schultzberg M, Bazan NG. Do KV, et al. Among authors: hjorth e. Cell Mol Neurobiol. 2023 Mar;43(2):797-811. doi: 10.1007/s10571-022-01216-5. Epub 2022 Apr 1. Cell Mol Neurobiol. 2023. PMID: 35362880 Free PMC article.
Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.
Tofiq A, Zetterberg H, Blennow K, Basun H, Cederholm T, Eriksdotter M, Faxén-Irving G, Hjorth E, Jernerén F, Schultzberg M, Wahlund LO, Palmblad J, Freund-Levi Y. Tofiq A, et al. Among authors: hjorth e. J Alzheimers Dis. 2021;83(3):1291-1301. doi: 10.3233/JAD-210007. J Alzheimers Dis. 2021. PMID: 34420949 Clinical Trial.
Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
Jernerén F, Cederholm T, Refsum H, Smith AD, Turner C, Palmblad J, Eriksdotter M, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Freund-Levi Y. Jernerén F, et al. Among authors: hjorth e. J Alzheimers Dis. 2019;69(1):189-197. doi: 10.3233/JAD-181148. J Alzheimers Dis. 2019. PMID: 30958356 Clinical Trial.
Amyloid-β Peptide Targeting Peptidomimetics for Prevention of Neurotoxicity.
Honcharenko D, Juneja A, Roshan F, Maity J, Galán-Acosta L, Biverstål H, Hjorth E, Johansson J, Fisahn A, Nilsson L, Strömberg R. Honcharenko D, et al. Among authors: hjorth e. ACS Chem Neurosci. 2019 Mar 20;10(3):1462-1477. doi: 10.1021/acschemneuro.8b00485. Epub 2019 Feb 6. ACS Chem Neurosci. 2019. PMID: 30673220
33 results